Breaking #AI #Health #Stock News: GBT
(OTCPK: $GTCHD) Started its AI System Training with Health-Related Big Data, Aiming
to Create an Intelligent Health Advisor Agent, Named Hippocrates; #Artificialintelligence
The Hippocrates system - an Avant! derivative,
will be trained with vast amounts of health-related information, using
accredited medical textbooks and health-related data resources
San Diego, CA, November 2, 2021 – (Investorideas.com Newswire) GBT Technologies Inc. (OTC PINK: GTCHD) ("GBT”, or the “Company”), is now training its Hippocrates system, an Avant! AI derivative system, with health-related big data, aiming to create an intelligent health advisory system. The company started “teaching” Avant! medical data using accredited medical textbooks used in medical schools. The AI system will learn the information to provide first line, health related advice and tips. Additionally, the company plans to connect with governmental and professional accredited data resources, among them are the CDC (Center of Dieses Control and Prevention - Centers for Disease Control and Prevention (cdc.gov)) and the NCBI (National Center for Biotechnology Information - National Center for Biotechnology Information (nih.gov)), as additional references.
Read this news, featuring
GTCHD in full at https://www.investorideas.com/CO/GOPH/news/2021/11021Hippocrates.asp
The
AI system is targeted to potentially understand a user’s question, analyze the
information conclude and advise. Hippocrates will be equipped with an initial
vast amount of health-related data and cognitively grow its knowledge over
time, learning from its own experiences, the same way a human does. The
system’s big data system incorporates components of data mining, statistics,
and predictive analysis, extracting knowledge and insights from huge amounts of
information. The system’s methodologies and algorithms provide a high precision
of big data analytics enabling reasoning and learning capabilities. Hippocrates
will be available through both web and mobile applications.
The
system’s main advantage potentially, is the capability to combine flexibility
and agility with rigorous data analysis; scientifically, extracting value from
huge data sets. It applies data science methods to address the needs of a new era
of intelligent healthcare, aiming to benefit patients and healthcare professionals,
addressing the challenges of providing rapid healthcare services anywhere around
the world. The company is evaluating monetizing the system via
clinics/hospitals licensing or individual’s fees.
“The
Hippocrates system is a derivative-system of our Avant! AI and is now under
massive data training to become an efficient data-driven information health
advisory agent. We are in the process of training Hippocrates with accredited
medical textbooks that are taught in medical schools. Additionally. we will be connecting
the Hippocrates system with governmental health resources, among them are CDC,
and the NCBI. The aim is to provide our AI agent with vast amount of health-related
materials to enable a first line health advice and tips. The system will have
cognitive capabilities to learn from its own experience and ultimately reason
and predict accordingly. The health advisor agent will interact with users through
a website interface and mobile application. GBT believes that artificial
intelligence solutions are going to become more prominent in our new era, and
plans to create a set of health-related solutions via hardware, qTerm device,
and supporting AI computer programs. Naturally, we plan to integrate the
Hippocrates system with our qTerm device sometime during 2022. These systems
aim to assist individuals and health professional to provide better and faster
healthcare anywhere around the world. The training of our Hippocrates system is
the first step of building an intelligent health advisory agent that learns
from vast data resources and its own experience; ultimately, becoming more
knowledgeable over time, as a human does,” said Danny Rittman the Company’s
CTO.
There
is no guarantee that the Company will be successful in researching, developing
or implementing this system. In order to
successfully implement this concept, the Company will need to raise adequate
capital to support its research and, if successfully researched, and fully developed,
the Company would need to enter into a strategic relationship with a third
party that has experience in manufacturing, selling and distributing this
product. There is no guarantee that the
Company will be successful in any or all of these critical steps.
About Us
GBT Technologies, Inc.
(OTC PINK: GTCHD) (“GBT”) (http://gbtti.com)
is a development stage company which considers itself a native of Internet of
Things (IoT), Artificial Intelligence (AI) and Enabled Mobile Technology
Platforms used to increase IC performance. GBT has assembled a team with extensive
technology expertise and is building an intellectual property portfolio
consisting of many patents. GBT’s mission, to license the technology and IP to
synergetic partners in the areas of hardware and software. Once commercialized,
it is GBT’s goal to have a suite of products including smart microchips, AI,
encryption, Blockchain, IC design, mobile security applications, database
management protocols, with tracking and supporting cloud software (without the
need for GPS). GBT envisions this system as a creation of a global mesh network
using advanced nodes and super performing new generation IC technology. The
core of the system will be its advanced microchip technology; technology that
can be installed in any mobile or fixed device worldwide. GBT’s vision is to
produce this system as a low cost, secure, private-mesh-network between any and
all enabled devices. Thus, providing shared processing, advanced mobile
database management and sharing while using these enhanced mobile features as
an alternative to traditional carrier services.
Forward-Looking Statements
Certain statements contained in this press
release may constitute "forward-looking statements". Forward-looking
statements provide current expectations of future events based on certain
assumptions and include any statement that does not directly relate to any
historical or current fact. Actual results may differ materially from those
indicated by such forward-looking statements as a result of various important
factors as disclosed in our filings with the Securities and Exchange Commission
located at their website ( http://www.sec.gov).
In addition to these factors, actual future performance, outcomes, and results
may differ materially because of more general factors including (without
limitation) general industry and market conditions and growth rates, economic
conditions, governmental and public policy changes, the Company’s ability to
raise capital on acceptable terms, if at all, the Company’s successful development
of its products and the integration into its existing products and the
commercial acceptance of the Company’s products. The forward-looking
statements included in this press release represent the Company's views as of
the date of this press release and these views could change. However,
while the Company may elect to update these forward-looking statements at some
point in the future, the Company specifically disclaims any obligation to do
so. These forward-looking statements should not be relied upon as
representing the Company's views as of any date subsequent to the date of the
press release.
Contact:
Dr. Danny Rittman, CTO
press@gopherprotocol.com
GBT Technologies Inc.
(OTCQB:GTCHD) is a featured tech stock on
More info on GTCHD at
Investorideas.com Visit: https://www.investorideas.com/CO/GOPH/
Get
News Alerts on GBT Technologies Inc GTCHD
Disclaimer/Disclosure: Investorideas.com is a digital
publisher of third party sourced news, articles and equity research as well as
creates original content, including video, interviews and articles. Original
content created by investorideas is protected by copyright laws other than
syndication rights. Our site does not make recommendations for purchases or
sale of stocks, services or products. Nothing on our sites should be construed
as an offer or solicitation to buy or sell products or securities. All
investing involves risk and possible losses. This site is currently compensated
for news publication and distribution, social media and marketing, content
creation and more. Disclosure is posted for each compensated news release, content
published /created if required but otherwise the news was not compensated for
and was published for the sole interest of our readers and followers.
Disclosure: GTCHD is a PR, social media and publishing client and compensates
Investorideas.com https://www.investorideas.com/About/News/Clientspecifics.asp
Contact management and IR of each company directly regarding specific questions.
More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn
more about publishing your news release and our other news services on the
Investorideas.com newswire https://www.investorideas.com/News-Upload/
and tickertagstocknews.com Global investors
must adhere to regulations of each country. Please read Investorideas.com
privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Get more tech stocks investor ideas- news, articles, podcasts and stock directories
